Most cited papers from Lundbeck (Denmark)

Lundbeck (Denmark)

What are the most cited papers from Lundbeck (Denmark)?

The most cited paper from Lundbeck (Denmark) is "Biological insights from 108 schizophrenia-associated genetic loci" (Stephan Ripke et al., 2014), with 8,181 citations. Next come "Cu-Catalyzed Azide−Alkyne Cycloaddition" (4,612) and "Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup" (2,670).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 319 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Biological insights from 108 schizophrenia-associated genetic loci Stephan Ripke et al. · Nature Open access297 authors	Jul 2014	8,181
2	Cu-Catalyzed Azide−Alkyne Cycloaddition Morten Meldal, Christian Wenzel Tornøe · Chemical Reviews Review	Aug 2008	4,612
3	Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia Open access	27 Jun 2024	2,670
4	Four deaths and a funeral: from caspases to alternative mechanisms Marcel Leist, Marja Jäättelä · Nature Reviews Molecular Cell Biology ReviewOpen access	Aug 2001	1,599
5	Community-led, integrated, reproducible multi-omics with anvi’o A. Murat Eren et al. · Nature Microbiology Open access	21 Dec 2020	1,028
6	α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells Christian Hansen, Élodie Angot, Ann‐Louise Bergström et al. · Journal of Clinical Investigation Open access	18 Jan 2011	854
7	Global mapping of pharmacological space Gaia Valeria Paolini, Richard H B Shapland, Willem P. van Hoorn et al. · Nature Biotechnology	Jul 2006	820
8	Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways Colm T. O'Dushlaine et al. · Nature Neuroscience Open access375 authors	19 Jan 2015	807
9	Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic Marcel Leist et al. · Science Open access	8 Jul 2004	805
10	SCH 23390—The first selective dopamine D-1 antagonist John Hyttel · European Journal of Pharmacology	Jul 1983	740
11	CNVs conferring risk of autism or schizophrenia affect cognition in controls Hreinn Stefánsson et al. · Nature Open access	18 Dec 2013	737
12	Recent Advances in Wave Function-Based Methods of Molecular-Property Calculations Trygve Ulf Helgaker, Sonia Coriani, Poul Jørgensen et al. · Chemical Reviews Review	11 Jan 2012	734
13	Lysosomes in cell death Maria Eugenia Guicciardi, Marcel Leist, Gregory James Gores · Oncogene Open access	12 Apr 2004	719
14	Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence J�rn Arnt · Neuropsychopharmacology Open access	Feb 1998	716
15	Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis Inge R. Holtman, Divya D. A. Raj, Jeremy A. Miller et al. · Acta Neuropathologica Communications Open access	21 May 2015	694
16	Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor Lasse Foghsgaard, Dorte Wissing, Daniel Mauch et al. · The Journal of Cell Biology Open access	21 May 2001	631
17	Influence of microemulsions on cutaneous drug delivery Mads Kreilgaard · Advanced Drug Delivery Reviews Review	Nov 2002	626
18	Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles Ralf Baron et al. · Pain Open access	3 Nov 2016	620
19	Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer Knut Nygaard, Steinar Hagen, Hanne Sand Hansen et al. · World Journal of Surgery	Nov 1992	620
20	Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder Benny Bang‐Andersen, Thomas M. Ruhland, Morten Jørgensen et al. · Journal of Medicinal Chemistry Open access	12 Apr 2011	604
21	Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity John Hyttel · Progress in Neuro-Psychopharmacology and Biological Psychiatry	1982	587
22	The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional Joshua D. Shrout, David L. Chopp, Collin L. Just et al. · Molecular Microbiology Open access	24 Oct 2006	585
23	Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data Connie Sánchez, Karen E. Asin, Francesc Artigas · Pharmacology & Therapeutics Open access	9 Jul 2014	545
24	Efficient ancestry and mutation simulation with msprime 1.0 Franz Baumdicker et al. · Genetics Open access	13 Dec 2021	543
25	The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways Günaj Rakipovski, Bidda Rolin, Jane Nøhr et al. · JACC Basic to Translational Science Open access	21 Nov 2018	517
26	Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Andreas Hald, Julie Lotharius · Experimental Neurology	4 Mar 2005	510
27	Chronic Pain, Chronic Stress and Depression: Coincidence or Consequence? Gordon Blackburn-Munro, Ruth E. Blackburn-Munro · Journal of Neuroendocrinology	Dec 2001	502
28	Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) John Hyttel · International Clinical Psychopharmacology	Mar 1994	495
29	The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves Mirko Manchia, Anouk W. Gathier, Hale Yapıcı Eser et al. · European Neuropsychopharmacology Open access	29 Oct 2021	492
30	Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene Karl F Mann, Anna Bladström, Lars Torup et al. · Biological Psychiatry	10 Dec 2012	482
31	Influence of Phasic and Tonic Dopamine Release on Receptor Activation Jakob Kisbye Dreyer, Kjartan Frisch Herrik, Rune W. Berg et al. · Journal of Neuroscience Open access	20 Oct 2010	445
32	A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder Cornelius Katona, Thomas Michael Hansen, Christina Kurre Olsen · International Clinical Psychopharmacology	8 May 2012	444
33	A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application Massimo Baroni, Gabriele Cruciani, Simone Sciabola et al. · Journal of Chemical Information and Modeling	9 Jan 2007	442
34	The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study Dyveke T. Demant, Karen Lund, Jan Vollert et al. · Pain	16 Aug 2014	442
35	Long-term temporal and spatial trends in eutrophication status of the Baltic Sea Jesper H. Andersen, Jacob Carstensen, Daniel J. Conley et al. · Biological reviews/Biological reviews of the Cambridge Philosophical Society ReviewOpen access	14 Oct 2015	441
36	Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Serhat Erbayraktar et al. · Proceedings of the National Academy of Sciences Open access	13 May 2003	437
37	A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults Roger S. McIntyre, Søren Lophaven, Christina Kurre Olsen · The International Journal of Neuropsychopharmacology Open access	30 Apr 2014	437
38	Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial Murat Emre, Magda Tsolaki, Ubaldo Bonuccelli et al. · The Lancet Neurology	22 Aug 2010	436
39	Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding Connie Sánchez, John Hyttel · Cellular and Molecular Neurobiology Open access	Aug 1999	434
40	Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group Kristian Uldall Kristiansen, Suzanne Hagen, T Kollevold et al. · Cancer	15 Feb 1981	422
41	Construction of implantable optical fibers for long-term optogenetic manipulation of neural circuits Dennis R. Sparta, Alice M. Stamatakis, Jana L. Phillips et al. · Nature Protocols Open access	8 Dec 2011	416
42	Kynurenines in CNS disease: regulation by inflammatory cytokines Brian Campbell, Erik I. Charych, Anna W. Lee et al. · Frontiers in Neuroscience Open access	2014	416
43	A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence Antoni Gual, Yuan He, Lars Torup et al. · European Neuropsychopharmacology	4 Apr 2013	404
44	Why still in hospital after fast-track hip and knee arthroplasty? Henrik Husted, Troels Haxholdt Lunn, Anders Troelsen et al. · Acta Orthopaedica Open access	9 Nov 2011	404
45	Reduced signal for polygenic adaptation of height in UK Biobank Jeremy J. Berg, Arbel Harpak, Nasa Sinnott-Armstrong et al. · eLife Open access	20 Mar 2019	395
46	Use of pharmaceutical salts and cocrystals to address the issue of poor solubility David P. Elder, René Holm, Heidi Lopez de Diego · International Journal of Pharmaceutics	24 Nov 2012	393
47	Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics Anne Vibeke Christensen, J�rn Arnt, John Hyttel et al. · Life Sciences	Apr 1984	376
48	In vitro models for the prediction of in vivo performance of oral dosage forms Edmund S. Kostewicz, Bertil Abrahamsson, Marcus Eli Brewster et al. · European Journal of Pharmaceutical Sciences Open access	27 Aug 2013	372
49	Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia Pascal Steullet, J-H Cabungcal, Joseph T. Coyle et al. · Molecular Psychiatry Open access	21 Mar 2017	370
50	Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics	20 Jun 2014	369

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.